Schrodinger Inc (SDGR) gains 2.31% for July 21

Equities Staff  |

Schrodinger Inc (NASDAQ: SDGR) shares gained 2.31%, or $1.61 per share, to close Wednesday at $71.26. After opening the day at $69.93, shares of Schrodinger fluctuated between $71.35 and $68.90. 285,282 shares traded hands a decrease from their 30 day average of 669,045. Wednesday's activity brought Schrodinger’s market cap to $4,371,155,171.

About Schrodinger Inc

Schrödinger is transforming the way therapeutics and materials are discovered. Schrödinger has pioneered a physics-based software platform that enables discovery of high-quality, novel molecules for drug development and materials applications more rapidly and at lower cost compared to traditional methods. The software platform is used by biopharmaceutical and industrial companies, academic institutions, and government laboratories around the world. Schrödinger's multidisciplinary drug discovery team also leverages its software platform to advance collaborative programs and its own pipeline of novel therapeutics to address unmet medical needs.

Visit Schrodinger Inc’s profile for more information.

About The Nasdaq Stock Market

The Nasdaq Stock Market is a global leader in trading data and services, and equities and options listing. Nasdaq is the world's leading exchange for options volume and is home to the five largest US companies - Apple, Microsoft, Amazon, Alphabet and Facebook.

To get more information on Schrodinger Inc and to follow the company’s latest updates, you can visit the company’s profile page here: Schrodinger Inc’s Profile. For more news on the financial markets be sure to visit Equities News. Also, don’t forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.

Sources: Chart is provided by TradingView based on 15-minute-delayed prices. All other data is provided by IEX Cloud as of 8:05 pm ET on the day of publication.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Market Movers

Sponsored Financial Content